Selection Process & Jury
Eligibility for the Prize for Excellence in Celiac Disease Research
The Prize Laureate must be an individual whose research has made a significant contribution to the field of celiac disease and must be living at the time of award and able to present their research at the Celiac Disease Foundation Annual Research Symposium. The Prize is awarded solely on the significance of clinical, translational, or transformative research and its impact on celiac disease patients, and is awarded based on actual research contributions, and not for the establishment or development of a research institution or research infrastructure.
To avoid the appearance of conflict of interest, employees of for-profit pharmaceutical or biotechnology companies will not be eligible. Prior Prize Laureates are not eligible for nomination, but prior nominees who were not selected in previous award cycles may be nominated in subsequent award cycles with no limit. Previous recipients of the Warren Prize for Excellence in Celiac Disease Research or the Maki Celiac Disease Tampere Prize are not eligible for nomination. English is the official language for the Prize administration, including the nomination process, deliberations, and associated materials as described herein.
Click here for more information about the Prize for Excellence in Celiac Disease Research.
Eligibility for the Young Investigator Prize
The Prize Laureate must be an investigator conducting original research in basic science, clinical care or translation in the field of celiac disease. The Prize Laureate must be a licensed physician, within 10 years of first appointment, and working in an academic or clinical setting with a current designation as either an Assistant or Associate Professor. The Prize Laureate must be living at the time of award and able to present their research at the Celiac Disease Annual Research Symposium.
The Prize will be awarded based on actual research contributions, and not for the establishment or development of a research institution or research infrastructure, and awarded solely on the significance of basic science, clinical, or translational research, and its impact on celiac disease patients. To avoid the appearance of conflict of interest, employees of for-profit pharmaceutical or biotechnology companies will not be eligible. Prior Prize Laureates are not eligible for nomination, but prior Nominees who were not selected in previous award cycles may be nominated in subsequent award cycles with no limit. Previous recipients of the Warren Prize for Excellence in Celiac Disease Research or the Maki Celiac Disease Tampere Prize are not eligible for nomination. English is the official language for the Prize administration, including the nomination process, deliberations, and associated materials as described herein.
Click here for more information about the Young Investigator Prize.
Open Call for Nomination Statements
Nominations for the Prizes are open worldwide and are made by members of the Selection Jury and are therefore not open to application. However, Nomination Statements will be accepted to afford the community at large an opportunity to suggest Nominees for the Prize to the Selection Jury. Statements must not exceed 500 words and must discuss the Nominee’s scientific achievements and their significance to the advancement of celiac disease research. Statements are confidential and only made available to members of the Selection Jury.
In addition to a signed Nomination Statement, the Selection Jury will need:
- CV, maximum three pages
- List of selected publications and patents
Nomination Statements and additional documents for Nominations are provided to the Jurors for consideration. Jurors may review these documents at their discretion. Any person writing a Nomination Statement is requested not to make direct contact with Jurors for the purpose of soliciting a recommendation for nominations or selection.
The deadline for the Open Call Nomination Statements is February 24, 2023.
Email Nominations to: [email protected]
The Prize Laureate will be notified by April 1, 2023. The Laureate will be announced at DDW2023 in Chicago, IL at a reception following the SSCD Annual Meeting where the Laureate will accept the Prize.
Selection Jury
The Selection Jury will be responsible for making nominations, deliberating over the Nominees, and selecting the Prize Laureate.
The Selection Jury is comprised of five Jurors. The Celiac Disease Foundation will select and appoint the Jurors, with priority given to individuals who have served in national or international capacities in the field of celiac disease research. Jurors may be reappointed in successive award cycles, with no limit to the number of reappointments. Jurors will receive an honorarium of $500 for their professional time, effort, and service.
In addition to the five Jurors, the Celiac Disease Foundation will appoint one Chairperson of the Selection Jury. The Chairperson is a non-voting member and will coordinate and moderate the selection process. An alternate Chairperson will also be appointed in the event that the Chairperson must recuse themselves due to a conflict of interest with any of the Nominees.
Jurors will be required to: 1) Identify two Nominees for the Prize. 2) Write a Nomination Statement not greater than 500 words for each Nominee. 3) Attend and participate in deliberations and make a brief oral presentation on the merits of his or her two Nominees to the Selection Jury.
If, for any reason, a Juror is unable to meet these requirements, he or she will be removed from the Jury.
